(LifeSiteNews) – Pfizer chairman and CEO Albert Bourla announced Monday that he has contracted COVID-19 despite having received multiple shots of his own company’s vaccine for the virus.
“I would like to inform the public that I have tested positive for COVID-19,” Bourla said in a press release. “I am grateful to have received four doses of the Pfizer-BioNTech vaccine and I am feeling well while experiencing very mild symptoms. I have started a course of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), I am isolating in place as well as following all public health precautions.”
“We have come so far in the past two years in our efforts to battle this disease that I am confident that I will have a speedy recovery,” he added. “I am incredibly grateful for the tireless efforts of my Pfizer colleagues who worked to make vaccines and treatments available for me and people around the world.”
Paxlovid, which has also been taken by President Joe Biden and was admitted to cause “rebound” cases in a minority of users, is the favored therapeutic of the federal government and the medical establishment. But The Blaze senior editor Daniel Horowitz writes that, “because it’s mixed with AIDS drug ritonavir, it is contraindicated with 32 entire classes of drugs, many of which are universal to those at risk for COVID because of other underlying conditions,” and notes that possible side effects acknowledged by the U.S. Food & Drug Administration include liver problems and high blood pressure.
“It’s true that a computer model study did show efficacy of Paxlovid as a protease binder against Omicron, but guess what?” Horowitz continues. “That same study concluded, ‘Ivermectin showed the highest binding affinity and may be the most effective drug candidate against the Omicron variant.’ Plus, ivermectin can be used later in the disease because of its anti-inflammatory and anti-coagulant properties.” Yet the public health establishment has been largely hostile to ivermectin.
Further, the case highlights the doubts many continue to harbor about the safety and effectiveness of the COVID shots, which were developed far more quickly than traditional vaccines under former President Donald Trump’s Operation Warp Speed initiative and have failed to stop the spread of the virus.
In March, it was found that 11,289 cases of pericarditis/myocarditis after COVID vaccination were reported to VAERS between January 1 and February 25, which is already 47% of the 24,177 reports for the same submitted in all of 2021. An April study out of Israel indicates that COVID infection alone cannot account for such cases despite claims to the contrary.
COVID shot defenders claim that VAERS offers an exaggerated view of a vaccine’s potential risks, as anyone can submit a report without vetting it, but the U.S. Centers for Disease Control & Prevention researchers have acknowledged “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.
But VAERS is not the only data source indicating cause for concern. Data from the Pentagon’s Defense Medical Epidemiology Database (DMED) has been similarly alarming, showing that 2021 saw drastic spikes in a variety of diagnoses for serious medical issues over the previous five-year average, including hypertension (2,181%), neurological disorders (1,048%), multiple sclerosis (680%), Guillain-Barre syndrome (551%), breast cancer, (487%), female infertility (472%), pulmonary embolism (468%), migraines (452%), ovarian dysfunction (437%), testicular cancer (369%), and tachycardia (302%).
Bourla’s Pfizer has also come under fire for its resistance to transparency about its vaccine. As covered by LifeSiteNews, the pharmaceutical giant has been fighting the release of trial data revealing how much the company knew about their mRNA-based vaccine’s risks.
Disclosures so far from the forced release of data that the company had initially tried to keep private until the year 2076 include reports of 158,893 serious adverse events after vaccination in dozens of countries from December 1, 2020 to February 28, 2022; and data showing that of 270 “unique pregnancies” that were exposed to the company’s vaccine, “no outcome was provided for 238 pregnancies,” and that of the 32 remaining pregnancies with known outcomes, 28 resulted in fetal death.